Autoantibodies to SOX1 are common in small-cell lung carcinoma (SCLC) and serve as a serological tumour marker for SCLC, while the role of a SOX1-related autoimmune response in SCLC is still elusive [3,4]. The gene discussed is SOX1; the disease is neoplasm.